WM | Jotup

BeiGene Announces Acceptance by Swissmedic of Marketing Authorization Application for BRUKINSA® (Zanubrutinib) in Waldenström’s Macroglobulinaemia

Retrieved on:

Wednesday, August 18, 2021

Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Union, Lancet, Private Securities Litigation Reform Act, Twitter, Blood, Lymphocytosis, SLL, Therapy, U.S. Securities and Exchange Commission, Incidence, Spleen, Completeness, Pharmacokinetics, MAA, Form 10-Q, Lymphoma, European Union, Tissue, Agency, CLL, Disease, Man, Mantle cell lymphoma, Lymph, Marketing, Lymphoid leukemia, Australia New Zealand Therapeutic Products Authority, Intellectual property, MCL, Senior, WM, Clinical trial, File, NASDAQ, Safety, Adult, BTK, Goal, Patient, Chronic lymphocytic leukemia, Half-life, Bone marrow, Commercial, COVID-19, ASPEN, Technology, Non-Hodgkin lymphoma, Pharmaceutical industry, Health insurance, Waldenström’s Macroglobulinemia, BRUKINSA (zanubrutinib), BeiGene, WALDENSTRöM’S MACROGLOBULINEMIA, BRUKINSA (ZANUBRUTINIB), BEIGENE

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that Swissmedic has accepted the marketing authorization application (MAA) for BRUKINSA, a treatment option for adult patients with Waldenstrms macroglobulinaemia (WM).

Key Points:

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that Swissmedic has accepted the marketing authorization application (MAA) for BRUKINSA, a treatment option for adult patients with Waldenstrms macroglobulinaemia (WM).
Gerwin Winter, Senior Vice President, Head of Commercial, Europe, at BeiGene said: The acceptance of the marketing authorization application of BRUKINSA by Swissmedic is a crucial step in the development of BRUKINSA for Swiss patients with WM.
The approval by Swissmedic would grant marketing authorization for BRUKINSA in WM within Switzerland.
Treatment and outcome patterns in European patients with Waldenstrms macroglobulinaemia: a large, observational, retrospective chart review.

Cellectar Announces Manufacturing and Supply Agreement with Evergreen Theragnostics for CLR-131, now known as iopofosine I-131

Retrieved on:

Monday, August 16, 2021

FLORHAM PARK, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that it has entered into a commercial manufacturing and supply agreement with Evergreen Theragnostics, a global radiopharmaceutical contract development and manufacturing organization (CDMO) based in Springfield, NJ. The company also announced that the United States Adopted Names Council (USAN) has approved the use of “iopofosine I-131” as the generic name for CLR-131.

Key Points:

Evergreen will conduct process development and validation of additional large scale commercial quantities of iopofosine I-131 at its newly constructed, state-of-the-art manufacturing facility designed specifically for radiopharmaceutical manufacturing, including therapeutic and diagnostic radiopharmaceuticals.
James Cook, CEO of Evergreen Theragnostics stated that, We welcome this new collaboration with Cellectar Biosciences.
Iopofosine I-131 represents a unique and novel class of radiotherapeutics and Evergreen is excited to participate in its continued development and long-term supply to patients.
Evergreen Theragnostics, established in 2019, is a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO).

Weedmaps Makes Purchasing Cannabis from Retailers Even Easier with In-App Ordering

Retrieved on:

Tuesday, August 10, 2021

Apples updated policy now allows Weedmaps customers to conduct their entire cannabis shopping experience from within the iOS app on their mobile device.

Key Points:

Apples updated policy now allows Weedmaps customers to conduct their entire cannabis shopping experience from within the iOS app on their mobile device.
Along with ordering on the Weedmaps iOS app, consumers will be able to review their order history and can chat with a customer support representative in real-time.
Additional in-app features include:
Savings: Browse local cannabis deals, sales, and promo codes from area retailers, all gathered for a simple, streamlined experience.
The cloud-based SaaS solutions from WM Business provide an end-to-end operating system for cannabis retailers.

Cellectar Reports Financial Results for the Second Quarter 2021 and Provides a Corporate Update

Retrieved on:

Monday, August 9, 2021

FLORHAM PARK, N.J., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc.(NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced financial results for the second quarter ended June 30, 2021 and provided a corporate update.

Key Points:

FLORHAM PARK, N.J., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc.(NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced financial results for the second quarter ended June 30, 2021 and provided a corporate update.
Median duration of response had not been reached, with 100% of the MYD88 wild type and high-risk patients exceeding 8.5 months.
During the second quarter, we remained focused on advancing both our preclinical and clinical objectives.
These forward-looking statements are made only as of the date hereof, and we disclaim any obligation to update any such forward-looking statements.

WM Technology, Inc. Announces Second Quarter 2021 Financial Results Conference Call

Retrieved on:

Tuesday, July 20, 2021

Software, Technology, Agriculture, Natural Resources, Economy of New York City, NASDAQ, WM, Cannabis, Finance, Medical specialties, Clinical medicine

WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading technology and software infrastructure provider to the cannabis industry, today announced it will report financial results for its second quarter ended June 30, 2021 after market close on Thursday, August 12, 2021. Management will host a conference call and webcast to discuss the Company's financial results at 2:00 p.m. Pacific Time (or 5:00 p.m. Eastern Time) on the same day.

Key Points:

WM Technology, Inc. (WM Technology or the Company) (Nasdaq: MAPS), a leading technology and software infrastructure provider to the cannabis industry, today announced it will report financial results for its second quarter ended June 30, 2021 after market close on Thursday, August 12, 2021.
Management will host a conference call and webcast to discuss the Company's financial results at 2:00 p.m. Pacific Time (or 5:00 p.m. Eastern Time) on the same day.
WM Technology, Inc.s (Nasdaq: MAPS) mission is to power a transparent and inclusive global cannabis economy.
Now in its second decade, WM Technology has been a driving force behind much of the legislative change weve seen in the past 10 years.

WM Technology, Inc. Announces Public Company Board of Directors

Retrieved on:

Wednesday, July 14, 2021

Software, Networks, General Health, Internet, Pharmaceutical, Data management, Technology, Security, Biotechnology, Alternative medicine, Medical Supplies, Health, WM, NASDAQ, Tony Aquila, Finance

WM Technology, Inc. (WM Technology or the Company) (Nasdaq: MAPS), a leading technology and software infrastructure provider to the cannabis industry, today announced the Companys Board of Directors following its public debut on the Nasdaq on June 16, 2021.

Key Points:

WM Technology, Inc. (WM Technology or the Company) (Nasdaq: MAPS), a leading technology and software infrastructure provider to the cannabis industry, today announced the Companys Board of Directors following its public debut on the Nasdaq on June 16, 2021.
Tony Aquila has served as a member of WM Technologys board of directors since June 2021.
Christopher Beals has served as WM Technologys Chief Executive Officer and as a member of its board of directors since June 2021.
Douglas Francis has served as a member of WM Technologys board of directors since June 2021.

Women In Trucking Association Announces Continued Gold Level Partnership with Waste Management

Retrieved on:

Monday, June 21, 2021

WM, Waste management, Waste management, Cision, Waste, Electronic waste, Companies, Articles, Economy, Trucking industry in the United States

PLOVER, Wis., June 21, 2021 /PRNewswire-PRWeb/ -- The Women In Trucking Association (WIT) announced today that Waste Management, Inc. (WM) has continued its Gold Level partnership, helping the nonprofit association encourage more women to see the vast opportunities in transportation, whether as a professional driver, mechanic, recruiter, business leader, and more.

Key Points:

PLOVER, Wis., June 21, 2021 /PRNewswire-PRWeb/ -- The Women In Trucking Association (WIT) announced today that Waste Management, Inc. (WM) has continued its Gold Level partnership, helping the nonprofit association encourage more women to see the vast opportunities in transportation, whether as a professional driver, mechanic, recruiter, business leader, and more.
In addition to providing financial support, the company actively participates in the association.
By joining with Women in Trucking, it illustrates how WM is a committed people first organization by supporting the advancement of women in the transportation industry," said Rooney.
"Influential industry leaders like Waste Management allow us to continue to make a lasting impact on gender diversity issues in the industry and advance our mission.

WM Motor Chooses BlackBerry QNX to Power Its W6 All-Electric SUV

Retrieved on:

Friday, May 7, 2021

Operating systems, Computer architecture, Computing, Embedded operating systems, Mobile operating systems, Real-time operating systems, Computing platforms, BlackBerry Limited, QNX, BlackBerry, WM, Icon

b'WATERLOO,ON and SHANGHAI, May 6, 2021 /PRNewswire/ -- BlackBerry Limited (NYSE: BB; TSX: BB) today announced that Chinese electric carmaker WM Motor hasselected its QNX Neutrino Realtime Operating System (RTOS) , QNX Software Development Platform (SDP 7.0) , and QNX Hypervisor to powerits advanced W6 SUV model.

Key Points:

b'WATERLOO,ON and SHANGHAI, May 6, 2021 /PRNewswire/ -- BlackBerry Limited (NYSE: BB; TSX: BB) today announced that Chinese electric carmaker WM Motor hasselected its QNX Neutrino Realtime Operating System (RTOS) , QNX Software Development Platform (SDP 7.0) , and QNX Hypervisor to powerits advanced W6 SUV model.
The model features brand-new electronic architecture and is powered by advanced silicon computer technology, a 5G base band and an autonomous driving domain controller.
"We are pleased to continue our partnership with WM Motor as they start to deploy the next generation of EV vehicles in the marketplace with advanced intelligence, functional safety, connectivity and security by leveraging the latest BlackBerry QNX technology platform.
"\n"As a forerunner of China\'s new energy vehicle market, WM Motor is committed to developing and delivering a safe, high-quality, reliable and affordable mobility experience for our customers," said Freeman Shen, Founder, Chairman and CEO of WM Motor.

WM Holding Company Announces Participation in the 2021 ICR Conference

Retrieved on:

Wednesday, January 6, 2021

Alternative medicine, Health, Technology, Software, General Health, Pharmaceutical, Weedmaps, Health sciences, WM, Medical cannabis, Pharmaceutical sciences, Health care

WM Holding Company, LLC (the Company) today announced that the Company is scheduled to participate in a presentation at the 2021 ICR Conference held virtually on Monday, January 11, 2021, at 12:30 pm Eastern Time.

Key Points:

WM Holding Company, LLC (the Company) today announced that the Company is scheduled to participate in a presentation at the 2021 ICR Conference held virtually on Monday, January 11, 2021, at 12:30 pm Eastern Time.
WM Holdings mission is to power a transparent and inclusive global cannabis economy.
WM Holding Company, LLC (WM Holding or WMH or the Company), parent company of Weedmaps and its WM Business SaaS offering, is the leading technology and software infrastructure provider to the cannabis industry.
Through its website and mobile apps, WM Holding provides consumers with the latest information, data and availability of cannabis products, facilitating product discovery.

Walmart Inc. to present at Barclays 2019 Global Consumer Staples Conference and the Goldman Sachs 26th Annual Global Retailing Conference

Retrieved on:

Thursday, August 29, 2019

Retail, Supermarket, Discount, Variety, Retailers, Retailing, Walmart, WMT, WM, Companies

Walmart Inc. (NYSE: WMT) announced today that Steve Bratspies, executive vice president and chief merchandising officer of Walmart U.S. will participate in a discussion at the Barclays 2019 Global Consumer Conference on Wednesday, Sept. 4 at 10:30 a.m. EDT.

Key Points:

Walmart Inc. (NYSE: WMT) announced today that Steve Bratspies, executive vice president and chief merchandising officer of Walmart U.S. will participate in a discussion at the Barclays 2019 Global Consumer Conference on Wednesday, Sept. 4 at 10:30 a.m. EDT.
He will also participate in a discussion at the Goldman Sachs 26th Annual Global Retailing Conference on Thursday, Sept. 5 at 12:05 p.m. EDT.
Transcripts of these sessions will be available after the events and will be archived on the companys website.
Additional information about Walmart can be found by visiting http://corporate.walmart.com , on Facebook at http://facebook.com/walmart and on Twitter at http://twitter.com/walmart .